BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025)
BioNTech SE (BNTX) posted Exchange Rate Effect of $1.6 million for Q4 2025, up 106.48% sequentially from -$25.1 million in Q3 2025, and down 88.79% YoY from $14.5 million in Q4 2024.
BioNTech SE (BNTX) Exchange Rate Effect (2018 - 2025) Analysis & Trends
BioNTech SE has reported Exchange Rate Effect for 8 years, with the latest figure at $1.6 million in Q4 2025.
- Quarterly Exchange Rate Effect fell 88.79% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$30.0 million (down 289.55% YoY) and the FY2025 annual result came in at -$30.5 million, down 292.88% from the prior year.
- Exchange Rate Effect grew to $1.6 million in Q4 2025 per BNTX's latest filing, from -$25.1 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $865.0 million in Q4 2022 and troughed at -$105.2 million in Q4 2021.
- A 5-year average of $57.5 million and a median of $4.5 million in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2021 and 2022: Exchange Rate Effect plunged 191894673.21% in 2021, then jumped 195979694.61% in 2022.
- Over 5 years, Exchange Rate Effect stood at -$105.2 million in 2021, then jumped by 921.86% to $865.0 million in 2022, then sank by 101.92% to -$16.6 million in 2023, then surged by 187.71% to $14.5 million in 2024, then tumbled by 88.79% to $1.6 million in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $1.6 million, -$25.1 million, and $10.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Sep 30, 2025 | -25.13 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Jun 30, 2025 | 10.41 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Mar 31, 2025 | -16.94 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Dec 31, 2024 | 14.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Jun 30, 2024 | -3.55 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Mar 31, 2024 | 7.39 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Dec 31, 2023 | -16.57 Mn |
| Sep 30, 2023 | 66.62 Mn |
| Sep 30, 2023 | 66.62 Mn |